Simplify Logo


Director – Competitive Intelligence

Posted on 6/5/2024

Revolution Medicines

Revolution Medicines

201-500 employees

Specializes in precision oncology therapies


Compensation Overview

$210k - $253kAnnually

+ competitive cash compensation + robust equity awards + strong benefits + significant learning and development opportunities


San Carlos, CA, USA

Computational Biology
Biology & Biotech
Required Skills
Data Analysis
  • Minimum of 5 years experience in competitive intelligence, market research, or a related field within the pharmaceutical and/or biotechnology industry
  • Demonstrated leadership, influencing skills, creativity, problem solving and ability to manage complexity
  • Experience in new product launches and pre-launch environments
  • Track record of being a collaborative team player, and adaptive to meet the needs of a growing business
  • Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines
  • Ability to represent Revolution Medicines well: strong interpersonal skills including verbal and written communication
  • Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients
  • Conduct thorough competitive and market assessments to identify market dynamics, trends, and potential impacts on Revolution Medicines’ pipeline, delivering insights to key stakeholders
  • Collaborate with stakeholders across the company (including Commercial, Medical Affairs, and R&D) to integrate internal and external information, analytics, and data
  • Coordinate and execute coverage of key medical congresses; outputs may include daily and post-conference summaries and post-conference summary presentations
  • Maintain an in-depth understanding of Revolution Medicines’ diverse product offerings, competitive positioning, and the broader market dynamics shaping the industry's future
  • Benchmark competitor clinical data, business models and capabilities to develop insights and recommendations that will help inform and refine Revolution Medicines’ strategy
  • Proactively facilitate the identification and prioritization of intelligence efforts critical to strategic planning and execution for key stakeholders and will provide direction for the design and refinement of intelligence plans

### Welcome to Revolution Medicines, crafting the future of oncology with precision. Our focus is on advancing RAS(ON) inhibitors and RAS Companion inhibitors, marked by the remarkable journey of our lead product, RMC-4630, through its clinical phases. Supported by a team of passionate oncology experts, we are steadfast in our mission to develop treatments that precisely target oncogenic mutations, promising a brighter, healthier tomorrow for patients everywhere. ###

Company Stage


Total Funding



Redwood City, California



Growth & Insights

6 month growth


1 year growth


2 year growth